Axonics stated that its ARTISAN-SNM study is a 129-patient single-arm, multi-center, unblinded pivotal clinical study, which has been approved by the FDA under Investigational Device Exemption (IDE) to
The post Axonics submits interim data to FDA for sacral neuromodulation system appeared first on Compelo Medical Devices.
Original Article: Axonics submits interim data to FDA for sacral neuromodulation system